CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 69 enrolled
Drug / intervention
UVB treatment +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04780776
NCT04780776N/ACompleted
CompareCT.gov

Evaluating the Effect of SOLIUS UV Light Source in Improving Serum Levels of 25-hydroxyvitamin D in Vitamin D Deficient/ Insufficient Adults of Various Skin Types

Boston University·interventional·Posted Mar 4, 2021·Updated Oct 22, 2024

In Brief

A clinical study evaluating UVB treatment and Sham comparator for Vitamin D Deficiency and Vitamin D Insufficiency. Completed, enrolled 69 participants across 1 site.

Detailed Summary

The aim of this study is to evaluate the safety and effectiveness of the SOLIUS System in improving serum levels of 25-hydroxyvitamin D in vitamin D deficient/ insufficient adults of various skin types. The investigators will conduct a double-blinded randomized clinical trial in 100 adults to compare the changes in serum 25-hydroxyvitamin D levels between subjects who received and do not receive weekly exposures to Ultraviolet B Radiation (UVB) generated by the SOLIUS System for 16 weeks.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVitamin D Deficiency, Vitamin D Insufficiency
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMar 4, 2021
Enrollment StartFeb 23, 2022
Primary CompletionNov 2, 2023
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 5.3 years ago

Interventions

UVB treatmentdevice

5 weeks of UVB titration to determine individual's UVB sensitivity followed by 16 weeks of UVB exposure intervention

Sham comparatordevice

5+16 weeks of visible light exposure